CREBBP and Sepsis: In this study, we have shown that SGC-CBP30 attenuated circulating HMGB1 levels even when the treatment was started at 8 h after sepsis modeling, and that HMGB1 induced the release of TNF-α, suggesting that CBP bromodomain might function as a regulator in controlling HMGB1.